Expert presentation

5-15 minutes

Eosinophils As a Biomarker for Type 2 Asthma – Dr. Israel

Topic: Burden Of Disease Pathophysiology Guidelines & recommendations

Tags: Eosinophils  Disease burden  Guidelines  Pathophysiology  Expert opinion 

Eosinophils As a Biomarker for Type 2 Asthma – Dr. Israel

15-minute video of Dr. Elliott lsrael presenting the utility of Eosinophils as a biomarker of type 2 inflammation and its role in the disease burden of asthma.

 

MAT-US-2207246 P-V1 10/28/2024

Welcome to the ADVENT program website

ADVENT is a medical education program by Sanofi and Regeneron. This website is intended only for health care professionals in the US only.

I AM A HEALTHCARE PROVIDER
I AM NOT A HEALTHCARE PROVIDER

ADVENT is a global medical education program by Sanofi and Regeneron and is only intended for healthcare providers.

You are leaving the ADVENT program website

Sanofi Genzyme does not review or control the content of non–Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of the site’s content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non–Sanofi Genzyme website.

LEAVE THIS SITE GO BACK TO ADVENT PROGRAM